Global Complement Inhibitors Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Global Complement Inhibitors Market is Segmented By Stage of Development (Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS) , Age-related Macular Degeneration (AMD), Myasthenia Gravis, Others), By Mechanism of Action (C5 Inhibitors, C3 Inhibitors, Terminal Complement Inhibitors, Others), By Route of Administration (Intravenous (IV), Subcutaneous (SC)), By End-User (Hospitals and Specialty Clinics, Retail Pharmacies , Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Global Complement Inhibitors Market Leaders

  • Alexion Pharmaceuticals (AstraZeneca)
  • Apellis Pharmaceuticals
  • Sanofi
  • CSL Behring
  • Takeda Pharmaceuticals
*Disclaimer: Major players are listed in no particular order.

Global Complement Inhibitors Market - Company List

  • Alexion Pharmaceuticals (AstraZeneca)
  • Apellis Pharmaceuticals
  • Sanofi
  • CSL Behring
  • Takeda Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Pharming Group
  • BioCryst Pharmaceuticals
  • Amgen
  • Omeros Corporation
  • Ionis Pharmaceuticals
  • Genentech (Roche)
  • Novartis
  • F. Hoffmann-La Roche
  • Eisai Co., Ltd.
  • Akari Therapeutics
  • Care Pharma
  • NovelMed Therapeutics
  • Zymeworks Inc.
  • Daiichi Sankyo

Global Complement Inhibitors Market Report Snapshots

Buy Now